Compared with its close competitors within the same industry, KOSDAQ, the monthly volatility of Genic was around the average of that of its peer group, but the investment return for 1 month was at an absolutely low level. Over the recent month, the return-on-risk, the return on investment with consideration about risk, was -1.9%. As bearish stock price trend, the return-on-risk was poor, compared with its peer group. Moreover, compared with the KOSDAQ industry, the return-on-risk is below the industrial mean, -0.7, and thus it is hard to say that the industrial comparison performance was positive. 

While institutions have been selling Genic during the past 7 trading days, foreigners have been buying during the past 3 trading days. As a shareholding sum by investor group for the past 4 weeks, foreigners have sold 28,905 shares with maintenance of a selling position and institutions have sold 29,987 shares with a selling trend. However, during the same period, individuals have bought 58,892 shares with an increasing position. 

By HeRo (hero@heraldcorp.com) 

This article is produced by the algorithm developed by the artificial intelligence developer ThinkPool in collaboration with Herald Corp.